Maccura Biotechnology Co.Ltd Stock
Equities
300463
CNE1000020H3
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.67 CNY | +0.19% |
|
-1.11% | -4.65% |
| Apr. 09 | China Provincial Regulators Approve Maccura Biotechnology's Blood Gas, Biochemistry Testing System | MT |
| Mar. 22 | Maccura Biotechnology Co.Ltd(XSEC:300463) dropped from FTSE All-World Index | CI |
| Capitalization | 6.45B 946M 803M 736M 699M 1.29B 88.02B 1.32B 8.64B 3.4B 42.47B 3.55B 3.48B 150B | P/E ratio 2025 * |
23.7x | P/E ratio 2026 * | 18.4x |
|---|---|---|---|---|---|
| Enterprise value | 6.45B 946M 803M 736M 699M 1.29B 88.02B 1.32B 8.64B 3.4B 42.47B 3.55B 3.48B 150B | EV / Sales 2025 * |
2.47x | EV / Sales 2026 * | 2.26x |
| Free-Float |
59.73% | Yield 2025 * |
1.5% | Yield 2026 * | 2.06% |
| 1 day | +0.19% | ||
| 1 week | -1.11% | ||
| Current month | -0.47% | ||
| 1 month | -4.05% | ||
| 3 months | -8.49% | ||
| 6 months | -7.30% | ||
| Current year | -4.65% |
| 1 week | 10.57 |  | 10.9 |
| 1 month | 10.4 | | 11.16 |
| Current year | 10.4 | | 14.2 |
| 1 year | 10.4 | | 14.2 |
| 3 years | 9.9 | | 17.63 |
| 5 years | 9.9 | | 49.34 |
| 10 years | 9.9 | | 65.24 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Jian Wu
CEO | Chief Executive Officer | 51 | 2017-06-21 |
Shan Yin
DFI | Director of Finance/CFO | 46 | 2021-10-25 |
Wen Jun Zhang
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Dai Guo Fu
BRD | Director/Board Member | 62 | 2019-01-21 |
Yong Tang
CHM | Chairman | 62 | 1994-10-19 |
Qi Lin Liu
BRD | Director/Board Member | 59 | 2009-11-21 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.19% | -1.11% | -9.73% | -39.75% | 946M | |
| +0.11% | -1.63% | -20.13% | -7.15% | 12.53B | |
| +0.79% | +10.78% | +102.51% | +270.20% | 11.95B | |
| +0.43% | +11.03% | - | - | 6B | |
| +0.18% | +2.82% | -17.12% | -6.29% | 5.46B | |
| -0.26% | +0.09% | -11.52% | -19.77% | 5.22B | |
| +6.54% | -6.58% | +117.56% | +77.93% | 4.94B | |
| +0.16% | +0.16% | -35.47% | -36.15% | 3.94B | |
| -5.71% | +4.28% | +227.43% | -53.75% | 3.14B | |
| -0.32% | +0.65% | -14.90% | -41.66% | 2.85B | |
| Average | +0.21% | +3.10% | +37.63% | +15.96% | 5.7B | |
| Weighted average by Cap. | +0.48% | +4.16% | +37.72% | +57.24% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.62B 384M 326M 298M 283M 524M 35.69B 535M 3.5B 1.38B 17.22B 1.44B 1.41B 60.85B | 2.85B 418M 355M 326M 309M 571M 38.92B 583M 3.82B 1.5B 18.78B 1.57B 1.54B 66.36B |
| Net income | 270M 39.61M 33.61M 30.8M 29.25M 54.06M 3.68B 55.22M 361M 142M 1.78B 149M 145M 6.28B | 350M 51.34M 43.57M 39.93M 37.92M 70.08M 4.77B 71.58M 468M 184M 2.3B 193M 189M 8.14B |
| Net Debt | - | - |
Employees
3,472
Calendar
Apr. 29 -
Earnings release - Annual 2025
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-04-20 | 10.67 ¥ | +0.19% | 4,125,082 |
| 26-04-17 | 10.65 ¥ | -1.93% | 7,023,900 |
| 26-04-16 | 10.86 ¥ | +0.37% | 4,356,200 |
| 26-04-15 | 10.82 ¥ | +0.28% | 5,142,882 |
| 26-04-14 | 10.79 ¥ | 0.00% | 4,792,900 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
10.67
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Equities
- 300463 Stock
Select your edition
All financial news and data tailored to specific country editions
